3Adachi M, Shibata A, Hayashi M, et al. Combined Preoperative ther- apy for oral cancer with nedaplatin and radiation [ J]. Gan To Kagaku Ryoho, 2002,29(3) :465 -467.
4Desoize B,Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment [ J ]. Crit Rev oncol Hematol,2002,42 (3) : 317 -325.
5Koenuma M, Kasai H, Uchlda N, et al. Pharmacokinetic correlation between experimental and clinical effects on human nonsmall cell lung cancers of cisdiammineglycolatoplatinum (254-S) and cisdiamminedi- chlomplatinum [ J ]. Anticancer Res, 1995,15 (2) :417 - 421.
6Koshiyama M, Kinezaki M, Uchida T, et al, Chemosensitivity testing of a novel platinum analog, nedaplatin( 254-S), in human gynecological carcinomas: a comparison with cisplatin[ J ]. AnticartcerRes ,2005,25 (6C) :499 -502.
7Kodama J ,Takemoto M ,Seki N ,et al ,Phase I study ofweekly nedapla- tin and concurrent pelvic radiotherapy as adjuvant therapy after radi- cal surgery for cervical cancer [ J ]. Int J Gynecol Cancer, 2008, 18 (5) :1037 - 1041.
8Tanaka T, YukawaK, Umesaki N. Radiation reduces carbo, platin sen- sitivity and cnhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro [ J ]. Eur J Gynaecol Oncol, 2007, 28 ( 5 ) : 352 -355.
9Berenice IA, Enoc-Mariano CM, Veronica AV,et al. Cervical carcino- ma in Southern Mexico : Human papillomavirus and cofactors [ J 1. Cancer Detection and Prevention,2009,32(4) :300 - 307.
10Marlow LA, Wailer J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer [ J ]. Br J Cancer,2007,97 ( 5 ) : 691 - 694.
